Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis: Kinetic Stabilization of the Native State
- 15 April 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 127 (18) , 6662-6671
Abstract
Transthyretin (TTR) amyloidogenesis requires rate-limiting tetramer dissociation and partial monomer denaturation to produce a misassembly competent species. This process has been followed by turbidity to identify transthyretin amyloidogenesis inhibitors including dibenzofuran-4,6-dicarboxylic acid (1). An X-ray cocrystal structure of TTR·12 reveals that it only utilizes the outer portion of the two thyroxine binding pockets to bind to and inhibit TTR amyloidogenesis. Herein, structure-based design was employed to append aryl substituents at C1 of the dibenzofuran ring to complement the unused inner portion of the thyroxine binding pockets. Twenty-eight amyloidogenesis inhibitors of increased potency and dramatically increased plasma TTR binding selectivity resulted. These function by imposing kinetic stabilization on the native tetrameric structure of TTR, creating a barrier that is insurmountable under physiological conditions. Since kinetic stabilization of the TTR native state by interallelic trans suppression is known to ameliorate disease, there is reason to be optimistic that the dibenzofuran-based inhibitors will do the same. Preventing the onset of amyloidogenesis is the most conservative strategy to intervene clinically, as it remains unclear which of the TTR misassembly intermediates results in toxicity. The exceptional binding selectivity enables these inhibitors to occupy the thyroxine binding site(s) in a complex biological fluid such as blood plasma, required for inhibition of amyloidogenesis in humans. It is now established that the dibenzofuran-based amyloidogenesis inhibitors have high selectivity, affinity, and efficacy and are thus excellent candidates for further pharmacologic evaluation.Keywords
This publication has 33 references indexed in Scilit:
- Liver Transplantation Does Not Prevent the Development of Life-Threatening Arrhythmia in Familial Amyloidotic Polyneuropathy, Portuguese-Type (ATTR Val30Met) PatientsTransplantation, 2004
- Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registryTransplantation, 2004
- Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of ActionAngewandte Chemie International Edition, 2003
- Screening Transthyretin Amyloid Fibril InhibitorsStructure, 2002
- Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 2002
- A comparative analysis of 23 structures of the amyloidogenic protein transthyretinJournal of Molecular Biology, 2000
- Alternative conformations of amyloidogenic proteins govern their behaviorCurrent Opinion in Structural Biology, 1996
- Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid DiseaseBiochemistry, 1995
- Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosisThe Lancet, 1993
- Palladium-catalyzed coupling of aryl triflates with organostannanesJournal of the American Chemical Society, 1987